Mounjaro 7.5mg

Mounjaro (tirzepatide) is a prescription medication approved for the management of type 2 diabetes. It acts as a dual GIP and GLP-1 receptor agonist, improving blood sugar control while often supporting weight loss. It is typically administered once weekly by subcutaneous injection.

Key Features:

FDA-approved treatment for type 2 diabetes

Dual action on GIP and GLP-1 receptors

May help with weight reduction in addition to glycemic control